Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC
SHANGHAI, July 2, 2026 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) today announced that it has entered into a strategic collaboration agreement with AstraZeneca (LSE/STO/NYSE: AZN) to...
Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-Class Single-Domain Antibody-Based BBB-Crossing Technology for CNS Diseases
CAMBRIDGE, Mass., July 2, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, today announced a strategic collaboration with Lonza to...
METiS TechBio and Boulevard Bio Enter Global License Agreement for Trispecific T-cell Engager
HONG KONG and NEW YORK, June 30, 2026 /PRNewswire/ -- METiS TechBio (7666.HK), a leading AI-driven drug delivery innovation company, today announced it has entered into an exclusive global licensing agreement with Boulevard Bio ("Boulevard"), a U.S....
Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China
SAN FRANCISCO and SUZHOU, China, June 30, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...
Tulip Innovation and Sunwoda Enter Patent License Agreement
BUDAPEST, Hungary and SHENZHEN, China, June 11, 2026 /PRNewswire/ -- Sunwoda Electronic (Sunwoda), a leading global provider of lithium-ion battery technologies and solutions, and Tulip Innovation (Tulip), the licensing agent for lithium-ion battery...
Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
SAN FRANCISCO and NEW YORK, and SUZHOU, China, May 29, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (01801.HK) and Pfizer Inc. (NYSE: PFE), today announced the companies have entered into a strategic global licensing and collaboration agreement for...
Herbalgy Trophy & "Goal-Getter Giveaway" - A Triumphant Return
Spend HK$180 Unlocks Your Shot at Over HK$1M in Match Tickets – 1,000 Tickets to Chelsea FC vs. Juventus at Kai Tak Buy More, Enter More HONG KONG, May 15, 2026 /PRNewswire/ -- Football fans can now experience the thrill of Chelsea FC vs Juventus...
Insilico Medicine and Ribo Enter Strategic Collaboration Agreement: Leveraging AI Platform and Automated Lab for End-to-End Empowerment of RNA Interference and Oligonucleotide Therapeutics Development
SHANGHAI, May 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a biotechnology company powered by generative artificial intelligence, today announced that the company has entered a strategic collaboration agreement with Suzhou Ribo...
Church's Texas Chicken® and Texas Chicken™ Enter China with Landmark 600-Restaurant Agreement
China Marks the Brand's 27th International Market, With First Shanghai Location Opening Summer 2026 ATLANTA, April 13, 2026 /PRNewswire/ -- Church's Texas Chicken ® and Texas Chicken ™, one of the largest quick-service chicken restaurant brands in...
AMTD IDEA Group's Controlling Shareholder, Directors and Executive Officers Enter into Voluntary Lock-up on Holdings
PARIS, NEW YORK and SINGAPORE, April 8, 2026 /PRNewswire/ -- AMTD IDEA Group ("AMTD IDEA Group") (NYSE: AMTD; SGX: HKB), a NYSE and SGX-ST dual-listed company and a subsidiary of AMTD Group Inc. ("AMTD Group"), today announced that AMTD Group and...